Background Primary open angle glaucoma (POAG) is a progressive optic neuropathy with
an elevated intraocular pressure (IOP), where the optic nerve head becomes pathologically …

Primary open-angle glaucoma (POAG) is a leading cause of blindness with no known cure.
Management of the disease focuses on lowering intraocular pressure (IOP) with current …

BACKGROUND: Much experience has been gained with the use of older classes of
antiglaucoma agents—topical beta-adrenergic-receptor antagonists, nonselective …

Timolol maleate is a non‐selective β‐adrenoceptor antagonist currently used mainly as an
ocular preparation for the treatment of glaucoma and ocular hypertension. Despite the …

AIMS To evaluate the short term cardiovascular, respiratory, and intraocular pressure (IOP)
effects of four glaucoma medications in newly diagnosed glaucoma patients. METHODS 141 …

Objective To test the hypotheses that (1) CYP2D6 genotype is associated with
pharmacokinetics of ophthalmic timolol and (2) variation in genotypes of ADRB1 (β 1 …

Purpose: To report on the medical treatments used for pediatric glaucomas. Patients and
Methods: A retrospective case series consisting of reviewing the medical notes of pediatric …

Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …

OBJECTIVE: To review published clinical information on the systemic adverse effects of
ophthalmic β-blockers for the purpose of developing a pilot contraindication/warning system …

Purpose: To investigate the use of topical ocular anti-glaucoma medications by
glaucomatous patients with obstructive pulmonary disease and their effect on related …